China

Medlinker sets up academic committee on AIDS internet diagnosis, treatment

It will guide the better application of Internet medical care in the prevention and control of AIDS.

Medlinker sets up academic committee on AIDS internet diagnosis, treatment

It will guide the better application of Internet medical care in the prevention and control of AIDS.

Pharmaceutical sales in China to reach CNY1.8t by 2030: Fitch

It is expected to grow at a CAGR of 5.7% over a ten-year forecast period. 

China-based Zhongchao to launch internet hospital

With this, the company now offers an all-in-one patient management service.

Ping An to build emergency management system

The system will help city managers to track epidemic conditions, real-time.

China to heighten competition for pharma exports to SSA

Nonetheless, India is still expected to be the region’s top supplier.

Sri Lanka opens largest nephrology hospital in South Asia

The hospital features 200 general inpatient beds and 100 hemodialysis beds.

China’s He Health rolls out online consultation services

The platform expanded its services after obtaining an internet hospital license.

China sets healthcare reform tasks for 2021

Emphasis will be placed on disease prevention in the country.

Chinese biopharmas eye collaboration with western firms

This could help them in promoting indigenous medicines.

Use of handheld ultrasounds on the rise in China

It found importance in treating patients in rural areas.

China to shift towards quality development for public hospitals

It also called for deepened reforms of medical service pricing.

China implements pharma patent reforms

It has introduced a patent term extension for drugs.

Growing demand and investments drive China’s ventilators market

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of mortality in the country.

China’s Renji Hospital launches IVF service app

It combines third-party assured data verification with blockchain technology.

China’s JD Health revamps online app

It has also introduced a new hotline service.

Subdued economy dampens multinational pharmas’ growth in China

Opportunities for MNCs exist largely in generics and OTC segments.